Paracetamol from Plastic: Terephthalic Acid as a Sustainable Pharmaceutical Intermediate
In the fast-paced pharmaceutical industry, where innovation and efficiency drive success, sustainability is also increasingly a concern given the limited nature of natural resources (Swaminathan, 2024).
July 8, 2025
by David Orchard-Webb
Predicted Top 5 Worldwide Selling Generic or Biosimilar Drugs in 2025
The global pharmaceutical market is approaching a phase in which several high-revenue medicines will lose patent protection, paving the way for generic and biosimilar competition (Scheckel, 2021).
July 8, 2025
by David Orchard-Webb
Predicted Top 5 Worldwide Selling Drugs in 2025: A Market Update
Keytruda ($30B sales), Ozempic, Mounjaro, Dupixent, and Skyrizi dominate 2025's pharma market, targeting oncology, diabetes/obesity, and immunology with breakthrough biologics and multi-indication strategies.
June 23, 2025
by David Orchard-Webb
Diabetes and Metabolic Disorders: The Approval of Teplizumab
Teplizumab, the first disease-modifying therapy for Type 1 diabetes, delays disease onset by ~4 years in high-risk individuals. Priced at $194,000 per course, it redefines early intervention despite cost barriers.
June 23, 2025
by David Orchard-Webb
Pharmacovigilance Regulations and Application: Safeguarding Drug Safety in a Complex Global Environment
In a pharmaceutical world characterized by rapid innovation and international marketplaces, safeguarding medication safety beyond commercialization has never been more important.
May 6, 2025
by David Orchard-Webb
Sterilization Processes in the Pharmaceutical Industry
In this post, we'll look at the numerous sterilization techniques utilized in the pharmaceutical sector, as well as their uses and benefits in terms of product safety and regulatory compliance.
May 6, 2025
by David Orchard-Webb
The Transformative Role of Blockchain in the Pharmaceutical Industry
The pharmaceutical business, long considered one of the most regulated and difficult sectors, is experiencing a digital transition.
April 21, 2025
by David Orchard-Webb
The Global ESG Rules and Regulations in the Pharmaceutical Industry: AstraZeneca Case Study
In the dynamic pharmaceutical sector, where innovation and regulatory compliance have long been the pillars of success, a new disruptive force is emerging: Environmental, Social, and Governance (ESG) principles
April 21, 2025
by David Orchard-Webb
Global Shingles (Herpes Zoster) Market Trends and Prospects
The global shingles market is growing due to factors like an aging population. It elaborates on drivers, segmentation, competition, and future trends.
March 18, 2025
by David Orchard-Webb
The Global Alpha-Glucosidase Inhibitor Market: Trends and Prospects
Alpha-glucosidase inhibitors are used for type 2 diabetes. This article analyzes their market, including growth, segments, and challenges.
March 18, 2025
by David Orchard-Webb
What Are Insulinotropic Polypeptides? How Are They Regulated?
Insulinotropic polypeptides like GIP and GLP-1 regulate insulin secretion. Retatrutide shows promise in treating obesity and MASLD. Related drugs face regulatory scrutiny and market is growing.
February 7, 2025
by David Orchard-Webb
Top Generalizable Antivirals for Stockpiling in Emergencies: A Review and Gap Analysis
Reviews top generalizable antivirals for emergency stockpiling, analyzes their pros & cons, and points out gaps in antiviral stockpile.
February 6, 2025
by David Orchard-Webb